In a memorandum prepared for an Oct. 26 meeting of the Circulatory System Devices Panel, the FDA expressed concerns about whether the AtriCure Synergy Ablation System — already approved and commercially available for the ablation of cardiac tissue — can be used to treat atrial fibrillation...